Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT01147133
Eligibility Criteria:
Inclusion Criteria:
* Patients in the maintenance phase of PCI receiving 1x75 mg clopidogrel and 1x100 mg aspirin
* No planned interruption of the antiplatelet therapy in the next 1 month
* Informed consent
Exclusion Criteria:
* Oral anticoagulant therapy
* Contraindication for aspirin or clopidogrel
* Planned interruption of antiplatelet therapy in the next month
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01147133
Study Brief:
Protocol Section:
NCT01147133